RESEARCH AND DEVELOPMENTQualitron Bio Medica has the Indian advantage, and we leverage on this. The advantage is that cost of drug development and discovery is less than one-fifth of that in the West. In addition, India has a huge talent pool of excellent doctors and scientists, who play an active role in drug discovery and drug development clinical trials. Moreover, these scientists and doctors are not restricted to allopathy. Our team comprises of nutraceutical and Ayurvedic scientists, which helps us to boast of a diverse product pipeline.
The present formulation development team is able to launch more than 20 products every year, which are bio-equivalent to international brands.
Our expertise spans instant and controlled-release products, complex injectables, and differentiated delivery systems. Simpler dosage forms handled include liquids, capsules, tablets, ointments, sterile ophthalmic preparations, and many more.
The R&D expertise of Qualitron Bio Medica and the capability to forge strategic alliances in terms of in-licensing agreements are the cornerstones of a vast product pipeline. This is a vital component of the company’s business strategy, which will enable it to have a long-term and sustainable competitive edge.
Our robust research program has developed alliances with numerous academic institutions and other organisations for hastening product discovery.